Jylamvo Solution
Product Images NDC 81927-204

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Jylamvo (NDC 81927-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Shorla Oncology Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Carton001)

Packaging label for Jylamvo (methotrexate) Oral Solution 2 mg/mL, manufactured by SGS Quay Pharmaceuticals Ltd. and distributed by Shorla Oncology Inc. The label includes dosing information, storage instructions, and a caution indicating it is a cytotoxic agent. The package size is 60 mL and the product is labeled for oral use only with a barcode present.*

FDA Label Image

Principal Display Panel (Label001)

Label for JYLAMVO (methotrexate) Oral Solution 2 mg/mL, a prescription oral liquid medication. The label includes a caution that it is a cytotoxic agent and instructions for pharmacists to dispense patient information. The product is supplied in a 60 mL bottle, manufactured by SGS Quay Pharmaceuticals Ltd., UK, and distributed by Shorla Oncology Inc., USA. Storage and handling instructions are provided.*

FDA Label Image

Structural Formula (Methotrexate Structure)

Chemical structure diagram of Methotrexate, the active ingredient in JYLAMVO oral solution 2 mg/mL by Shorla Oncology Inc. The image shows the molecular formula with labeled atoms and bonds representing the chemical composition of Methotrexate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.